Schedule 13G ownership disclosure

DICERNA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 253031108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
1.7580%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-19-000980
Form type
SC 13G/A
Filer
Dicerna Pharmaceuticals Inc
CIK
CIK 1399529
Filed
Feb 13, 2019
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub